StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$5.97−0.17 (-2.77%)

Close on Nov 20, 2026Market cap $268.77MP/E –Yield –

Agenus net income

Net income is the profit left for shareholders after every expense, interest and tax.

Agenus's net income for the twelve months ending Dec 31, 2020 was -$182.89M. For fiscal 2017 it was -$120.69M. The highest annual figure on record is -$11.32M in fiscal 2012.

Annual net income

PeriodPeriod endValueChange
FY2017Dec 31, 2017-$120.69M–
FY2016Dec 31, 2016-$127.00M–
FY2015Dec 31, 2015-$87.88M–
FY2014Dec 31, 2014-$42.49M–
FY2013Dec 31, 2013-$30.07M–
FY2012Dec 31, 2012-$11.32M–
FY2011Dec 31, 2011-$23.28M–
FY2010Dec 31, 2010-$21.91M–
FY2009Dec 31, 2009-$30.32M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020-$37.73M–
Q3 FY2020Sep 30, 2020-$51.65M–
Q2 FY2020Jun 30, 2020-$48.24M–
Q1 FY2020Mar 31, 2020-$45.27M-359.7%
Q4 FY2019Dec 31, 2019-$30.85M–
Q3 FY2019Sep 30, 2019-$46.28M–
Q2 FY2019Jun 30, 2019-$51.87M–
Q1 FY2019Mar 31, 2019$17.44M–
Q4 FY2018Dec 31, 2018-$48.85M–
Q3 FY2018Sep 30, 2018-$33.73M–
Q2 FY2018Jun 30, 2018-$25.20M–
Q1 FY2018Mar 31, 2018-$54.26M–
Q4 FY2017Dec 31, 2017-$35.04M–
Q3 FY2017Sep 30, 2017-$36.84M–
Q2 FY2017Jun 30, 2017-$31.71M–
Q1 FY2017Mar 31, 2017-$17.10M–
Q4 FY2016Dec 31, 2016-$26.12M–
Q3 FY2016Sep 30, 2016-$40.77M–

More Agenus figures

See a number that looks wrong?